Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2012 Feb 8;83(1):14–21. doi: 10.3109/17453674.2011.652886

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Nordic Orthopaedic Federation

This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited.

PMC Copyright notice

Figure 4. — Discrimination of postoperative venous thromboembolism (VTE) using levels of soluble fibrin (SF) and plasminogen activator inhibitor type 1 (PAI-1). Increases in either SF or PAI-1 on postoperative day 1 above their cut-off levels provided 100% sensitivity and 67% specificity in predicting VTE when patients were not given fondaparinux sodium postoperatively (left panel). In addition, when this criterion was applied to patients who received subcutaneous injections of fondaparinux following surgery, 7 of the 8 patients with VTE met the criterion and a 98% (48/49) negative agreement rate was found (right panel).